BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24983019)

  • 1. Hepatitis C Prevention and Needle Exchange Programs in Rhode Island: ENCORE.
    Joseph R; Kofman A; Larney S; Fitzgerald P
    R I Med J (2013); 2014 Jul; 97(7):31-4. PubMed ID: 24983019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhode Island's Syringe Exchange Program (ENCORE).
    Latta ET
    Med Health R I; 2000 Jul; 83(7):216-8. PubMed ID: 10934826
    [No Abstract]   [Full Text] [Related]  

  • 3. Backpack needle exchange: background, design, and pilot testing of a program in Rhode Island.
    Hebert MR; Caviness CM; Bowman SE; Chowdhury SP; Loberti PG; Stein MD
    J Addict Dis; 2008; 27(3):7-12. PubMed ID: 18956524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and treatment of hepatitis C in illicit drug users].
    Sakoman S
    Acta Med Croatica; 2009 Dec; 63(5):437-42. PubMed ID: 20198904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe exchange programs --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and control of hepatitis C in rhode island.
    Alexander-Scott NE; Lemire A; Larson HE; Bandy U
    R I Med J (2013); 2014 Jul; 97(7):25-8. PubMed ID: 24983017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAPT: Association for Drug Abuse and Prevention and Treatment.
    Cintron M
    Newsline People AIDS Coalit N Y; 1998 Jun; ():13-7. PubMed ID: 11367467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California.
    Clarke K; Harris D; Zweifler JA; Lasher M; Mortimer RB; Hughes S
    Soc Work Public Health; 2016; 31(5):398-407. PubMed ID: 27167664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global epidemiology of hepatitis C virus infection.
    Shepard CW; Finelli L; Alter MJ
    Lancet Infect Dis; 2005 Sep; 5(9):558-67. PubMed ID: 16122679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Equity, Social Justice, and HIV in Rhode Island: A Contemporary Challenge.
    Bertrand T; Chan PA; Howe K; Comella J; Marak T; Bandy U
    R I Med J (2013); 2016 Nov; 99(11):21-24. PubMed ID: 27801915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
    Hallinan R; Byrne A; Dore GJ
    Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and HCV testing for young drug users in Rhode Island.
    Pugatch D; Anderson BJ; O'Connell JV; Elson LC; Stein MD
    J Adolesc Health; 2006 Mar; 38(3):302-4. PubMed ID: 16488833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS in Staten Island.
    Levine E
    Body Posit; 1998 Jan; 11(1):23-9, 32-3. PubMed ID: 11365009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.